Artificial intelligence software standardizes electrogram-based ablation outcome for persistent atrial fibrillation.


Journal

Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756

Informations de publication

Date de publication:
11 2022
Historique:
revised: 15 04 2022
received: 16 03 2022
accepted: 04 07 2022
pubmed: 23 8 2022
medline: 15 11 2022
entrez: 22 8 2022
Statut: ppublish

Résumé

Multiple groups have reported on the usefulness of ablating in atrial regions exhibiting abnormal electrograms during atrial fibrillation (AF). Still, previous studies have suggested that ablation outcomes are highly operator- and center-dependent. This study sought to evaluate a novel machine learning software algorithm named VX1 (Volta Medical), trained to adjudicate multipolar electrogram dispersion. This study was a prospective, multicentric, nonrandomized study conducted to assess the feasibility of generating VX1 dispersion maps. In 85 patients, 8 centers, and 17 operators, we compared the acute and long-term outcomes after ablation in regions exhibiting dispersion between primary and satellite centers. We also compared outcomes to a control group in which dispersion-guided ablation was performed visually by trained operators. The study population included 29% of long-standing persistent AF. AF termination occurred in 92% and 83% of the patients in primary and satellite centers, respectively, p = 0.31. The average rate of freedom from documented AF, with or without antiarrhythmic drugs (AADs), was 86% after a single procedure, and 89% after an average of 1.3 procedures per patient (p = 0.4). The rate of freedom from any documented atrial arrhythmia, with or without AADs, was 54% and 73% after a single or an average of 1.3 procedures per patient, respectively (p < 0.001). No statistically significant differences between outcomes of the primary versus satellite centers were observed for one (p = 0.8) or multiple procedures (p = 0.4), or between outcomes of the entire study population versus the control group (p > 0.2). Interestingly, intraprocedural AF termination and type of recurrent arrhythmia (i.e., AF vs. AT) appear to be predictors of the subsequent clinical course. VX1, an expertise-based artificial intelligence software solution, allowed for robust center-to-center standardization of acute and long-term ablation outcomes after electrogram-based ablation.

Identifiants

pubmed: 35989543
doi: 10.1111/jce.15657
pmc: PMC9826214
doi:

Substances chimiques

Anti-Arrhythmia Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2250-2260

Subventions

Organisme : Volta Medical
Organisme : Hopital Saint Joseph

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Authors. Journal of Cardiovascular Electrophysiology published by Wiley Periodicals LLC.

Références

Europace. 2017 Aug 01;19(8):1302-1309
pubmed: 28204452
Heart Rhythm. 2009 Jan;6(1):33-40
pubmed: 19121797
Comput Biol Med. 2017 Oct 1;89:389-396
pubmed: 28869899
J Am Coll Cardiol. 2009 Mar 3;53(9):782-9
pubmed: 19245970
JAMA. 2020 Oct 27;324(16):1620-1628
pubmed: 33107945
N Engl J Med. 2015 May 7;372(19):1812-22
pubmed: 25946280
Circ Arrhythm Electrophysiol. 2017 Jul;10(7):
pubmed: 28687670
J Am Coll Cardiol. 2012 Aug 14;60(7):628-36
pubmed: 22818076
J Cardiovasc Electrophysiol. 2022 Nov;33(11):2250-2260
pubmed: 35989543
Pacing Clin Electrophysiol. 2011 Aug;34(8):939-48
pubmed: 21501179
Circ Arrhythm Electrophysiol. 2020 Aug;13(8):e008160
pubmed: 32631100
JACC Clin Electrophysiol. 2019 Jul;5(7):817-829
pubmed: 31320010
Circulation. 2014 Aug 12;130(7):530-8
pubmed: 25028391
Nat Med. 2019 Jan;25(1):30-36
pubmed: 30617336
J Am Coll Cardiol. 2004 Jun 2;43(11):2044-53
pubmed: 15172410
Circulation. 2005 Aug 9;112(6):789-97
pubmed: 16061740
Circ Arrhythm Electrophysiol. 2011 Oct;4(5):609-14
pubmed: 21856772
J Am Coll Cardiol. 2017 Jan 24;69(3):303-321
pubmed: 28104073
Int J Cardiol. 2019 Mar 1;278:97-103
pubmed: 30587415
Circ Arrhythm Electrophysiol. 2019 Jul;12(7):e007233
pubmed: 31242746
Europace. 2018 Jan 1;20(1):e1-e160
pubmed: 29016840
J Cardiovasc Electrophysiol. 2021 Aug;32(8):2148-2158
pubmed: 34041824
Circ Arrhythm Electrophysiol. 2020 Jan;13(1):e007825
pubmed: 31944826
Heart Rhythm. 2014 Apr;11(4):579-86
pubmed: 24418165
Circ Arrhythm Electrophysiol. 2016 Mar;9(3):
pubmed: 26966286
J Interv Card Electrophysiol. 2006 Sep;16(3):153-67
pubmed: 17103313

Auteurs

Julien Seitz (J)

St. Joseph Hospital, Marseille, France.

Théophile Mohr Durdez (TM)

Volta Medical, Marseille, France.

Jean P Albenque (JP)

Clinique Pasteur, Toulouse, France.

André Pisapia (A)

St. Joseph Hospital, Marseille, France.

Edouard Gitenay (E)

St. Joseph Hospital, Marseille, France.

Cyril Durand (C)

Infirmerie Protestante, Caluire-et-Cuire, France.

Jacques Monteau (J)

St. Joseph Hospital, Marseille, France.

Ghassan Moubarak (G)

Clinique Ambroise Paré, Neuilly-sur-Seine, France.

Guillaume Théodore (G)

University Hospital, Nice, France.

Antoine Lepillier (A)

Centre Cardiologique du Nord, Saint-Denis, France.

Alexandre Zhao (A)

Clinique Ambroise Paré, Neuilly-sur-Seine, France.

Michel Bremondy (M)

St. Joseph Hospital, Marseille, France.

Alexandre Maluski (A)

St. Joseph Hospital, Marseille, France.

Bruno Cauchemez (B)

Clinique Ambroise Paré, Neuilly-sur-Seine, France.

Stéphane Combes (S)

Clinique Pasteur, Toulouse, France.

Yves Guyomar (Y)

Saint-Philibert Hospital, Lomme, France.

Sébastien Heuls (S)

Saint-Philibert Hospital, Lomme, France.

Olivier Thomas (O)

Clinique Ambroise Paré, Neuilly-sur-Seine, France.

Guillaume Penaranda (G)

Alphabio laboratory, Marseille, France.

Sabrina Siame (S)

St. Joseph Hospital, Marseille, France.

Anthony Appetiti (A)

Volta Medical, Marseille, France.

Paola Milpied (P)

Volta Medical, Marseille, France.

Clément Bars (C)

St. Joseph Hospital, Marseille, France.

Jérôme Kalifa (J)

Brown University, Providence, Rhode Island, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH